what is brand name of tirzepatide Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research 🧠Let's break the drug tirzepatide

Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases

Both medications act on appetite-regulating centers of the brain to reduce food cravings and hunger, says Dan Maselli, M.D., a board-certified internal medicine, gastroenterology, and obesity medicine physician

Confirmed for 2026 Health New England Dropping Coverage Starting January 1, 2026 , Health New England will no longer cover Zepbound, Saxenda, or Wegovy for Individual and Small Group members

Unfortunately, these methods have not been approved by the FDA and, as a general rule, Medicare will only cover FDA-approved treatments

A few drugs fall into this category, and youll hear all of them lumped together in the muscle loss conversation

Most patients find they naturally eat smaller portions and make better food decisions as their cravings decrease and their appetite adjusts